Editorial Produção Nacional Revisado por pares

Lowering PSA cutoffs to enhance detection of curable prostate cancer

2000; Elsevier BV; Volume: 55; Issue: 6 Linguagem: Inglês

10.1016/s0090-4295(99)00602-0

ISSN

1527-9995

Autores

William J. Catàlona, Christian G. Ramos, Gustavo Franco Carvalhal, Ying Yan,

Tópico(s)

Bladder and Urothelial Cancer Treatments

Resumo

The widespread use of serum prostate-specific antigen (PSA) testing for early prostate cancer detection has increased the proportion of early-stage cancers detected and is at least partially responsible for the recent decrease in prostate cancer mortality rates in the United States.1

Referência(s)
Altmetric
PlumX